IPAM
VRTX icon

ICICI Prudential Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

ICICI Prudential Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Buy
4,209
+138
+3% +$64.3K 0.23% 97
2025
Q4 		$1.85M Buy
4,071
+134
+3% +$57.8K 0.22% 97
2025
Q3 		$1.54M Buy
3,937
+719
+22% +$300K 0.16% 103
2025
Q2 		$1.43M Sell
3,218
-75
-2% -$34.6K 0.18% 97
2025
Q1 		$1.6M Sell
3,293
-60
-2% -$28K 0.21% 88
2024
Q4 		$1.35M Sell
3,353
-16
-0.5% -$7.42K 0.15% 94
2024
Q3 		$1.57M Buy
3,369
+535
+19% +$257K 0.17% 90
2024
Q2 		$1.33M Buy
2,834
+263
+10% +$114K 0.16% 93
2024
Q1 		$1.07M Buy
2,571
+70
+3% +$29.6K 0.12% 98
2023
Q4 		$1.02M Buy
2,501
+205
+9% +$75.7K 0.12% 89
2023
Q3 		$798K Buy
2,296
+545
+31% +$191K 0.1% 92
2023
Q2 		$616K Buy
1,751
+105
+6% +$35.4K 0.08% 98
2023
Q1 		$519K Buy
1,646
+357
+28% +$107K 0.08% 93
2022
Q4 		$372K Buy
1,289
+348
+37% +$106K 0.06% 89
2022
Q3 		$272K Buy
941
+179
+23% +$51.5K 0.04% 92
2022
Q2 		$214K Buy
762
+31
+4% +$8.3K 0.04% 95
2022
Q1 		$188K Buy
731
+104
+17% +$24.7K 0.03% 97
2021
Q4 		$138K Buy
+627
New +$122K 0.02% 100

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ICICI Prudential Asset Management's VRTX Position: Q1 2026 in Review

ICICI Prudential Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 3.4% in Q1 2026, buying an estimated $64.3K and bringing the position to 4,209 shares worth $1.88M. The position accounts for 0.23% of the portfolio, ranked #97.

ICICI Prudential Asset Management first reported a position in VRTX in Q4 2021 and has held it in 18 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • ICICI Prudential Asset Management held 4,209 shares of Vertex Pharmaceuticals worth $1.88M as of Q1 2026.
  • ICICI Prudential Asset Management bought 138 Vertex Pharmaceuticals shares in Q1 2026, an estimated $64.3K.
  • Vertex Pharmaceuticals made up 0.23% of ICICI Prudential Asset Management's portfolio in Q1 2026, its #97 holding.
  • ICICI Prudential Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on ICICI Prudential Asset Management's 13F filing for Q1 2026, filed 11 May 2026.